Sichenzia Ross Friedman Ference LLP Advises Cell Source, Inc. on $500,000 PIPE Financing

cell source

New York, NY – April 1, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Cell Source, Inc. (OTCQB: CLCS), a biomedical technology company focused on developing cell therapy treatments, on an offering pursuant to which Cell Source issued and sold two promissory notes in the aggregate amount of $500,000 and two Warrants to purchase common stock to two accredited investors.

The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia and Associate Jay Yamamoto.

Media Contact:

pr@srfkllp.com
(212)-930-9700

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP